Paramesu Biotechs IPO aims to raise ₹600 crore for expansion and debt repayment, showcasing strong financial performance and ...

The diversified product portfolio includes native maize starch, modified maize starches, liquid glucose, maltodextrin powder, ...

Its products include liquid glucose, dried glucose solids, maltodextrin powder, dextrose monohydrate, native maize starches, modified maize starches, and co-products like germs, gluten ...